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Abstract 
Background: Obtaining sufficient quantities of recombinant M.tb proteins using traditional approaches is often 
unsuccessful. Several enzymes of the glycolytic cycle are known to be multifunctional, however relatively few 
enzymes from M.tb H37Rv have been characterized in the context of their enzymatic and pleiotropic roles. One of the 
primary reasons is the difficulty in obtaining sufficient amounts of functionally active protein.
Results: In the current study, using M.tb glyceraldehyde-3-phosphate dehydrogenase (GAPDH) we demonstrate that 
expression in E. coli or M. smegmatis results in insolubility and improper subcellular localization. In addition, expression 
of such conserved multisubunit proteins poses the problem of heteromerization with host homologues. Importantly 
the expression host dramatically affected the yield and functionality of GAPDH in terms of both enzymatic activity 
and moonlighting function (transferrin binding). The applicability of this system was further confirmed using two 
additional enzymes i.e. M.tb Pyruvate kinase and Enolase.
Conclusions: Our studies establish that the attenuated strain M.tb H37Ra is a suitable host for the expression of 
highly hydrophobic, conserved, multimeric proteins of M.tb H37Rv. Significantly, this expression host overcomes the 
limitations of E. coli and M. smegmatis expression and yields recombinant protein that is qualitatively superior to that 
obtained by traditional methods. The current study highlights the fact that protein functionality (which is an an essen-
tial requirement for all in vitro assays and drug development) may be altered by the choice of expression host.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Globally several laboratories are involved in identifying 
Mycobacterium tuberculosis (M.tb) proteins that play a 
crucial role in immunomuodulation, gene regulation, 
pathogenesis and virulence with the aim of developing 
novel anti-mycobacterials. Functional characterization 
of these activities requires large quantities of purified 
protein and commonly, recombinant M.tb proteins are 
expressed in available E. coli strains. However, due to 
their high GC content and intrinsic hydrophobicity the 
products are often functionally inactive. To overcome 
this problem multiple approaches have been attempted 
including: (1) optimization of refolding or growth con-
ditions [1], (2) changing the tag or strain to enhance 
solubility [2], (3) creating strains with compatible codon 
usage [3] and (4) expression in M. smegmatis which is 
a fast growing strain, closely related to M. tuberculosis 
[4–6].
Numerous microbial pathogens utilize the alter-
nate functions of glycolytic and TCA cycle enzymes 
to enhance their virulence [7]. Bacterial GAPDH has 
been associated with multiple functions including as 
an adhesin, invasin and an EGF binding protein [7, 
8]. Recently we demonstrated that in pathogenic M.tb 
H37Rv, GAPDH and other conserved proteins function 
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as receptors for the uptake of transferrin and consequent 
iron acquisition by the pathogen [9].
As reported previously, M.tb GAPDH has significant 
solubility issues and complete characterization of the 
enzyme has not been possible [10]. While attempting to 
validate the role of M.tb GAPDH as a transferrin receptor 
we were unable to obtain sufficient quantities of stable 
recombinant protein using E. coli [10] or M. smegmatis 
as host strains.
The current study demonstrates that M.tb H37Ra 
can be utilized as a host for the successful expression 
and purification of recombinant M.tb H37Rv proteins. 
Expression in M. tuberculosis H37Ra exhibited ~99  % 
purity with an improved yield of stable and function-
ally active enzyme. The majority of recombinant protein 
was localized in the cytosol as opposed to significant 
incorporation into the membrane and cell wall fractions 
upon expression in E. coli or M. smegmatis. In addition 
as GAPDH is a highly conserved multisubunit protein we 
also observed that expression in M. smegmatis resulted in 
the formation of a chimeric protein incorporating both 
host and vector components. Functional characteriza-
tion revealed that enzyme activity significantly differed 
between proteins purified from each of these hosts. The 
alternate moonlighting function of GAPDH i.e. transfer-
rin binding also varied depending on the source of the 
protein. To confirm the utility of this expression system, 
two additional multimeric M.tb proteins Enolase and 
Pyruvate kinase (PykA) were also successfully expressed 
in M.tb H37Ra. As with GAPDH, we observed significant 
differences in the yield, heteromerization and enzyme 
activity as compared to recombinant protein obtained 
from E. coli or M. smegmatis host strains. Overall, this 
study identifies an expression system suitable for M.tb 
H37Rv proteins that retains both solubility and func-
tionality. This study encompasses aspects of tuberculosis 
research that require recombinant proteins of the human 
pathogenic strain M.tb H37Rv including enzymology, 




Recombinant M.tb GAPDH (rGAPDH) was expressed 
in three different strains viz. E.  coli, M. smegmatis and 
M. tuberculosis H37Ra, protein purified from these host 
strains are referred to as EC-H-GAPDH, MS-H-GAPDH, 
MT-H-GAPDH, MS-GAPDH-H, MT-GAPDH-H to 
reflect the expression host, position of Histidine tag and 
protein.
Localization of rGAPDH was evaluated in different cell 
fractions of E. coli BL21DE3 GroEL/GroES. A majority 
of protein was present in the cell wall and inclusion body 
fractions (Additional file  1: Figure  1a, b). The GAPDH 
gene was cloned in a high copy number E. coli-M.tb shut-
tle vector to allow expression of the His-tagged protein 
in M. smegmatis. Cytosol, cell membrane and cell wall 
fractions were prepared from control (untransformed) 
or rGAPDH expressing M. smegmatis strains. The pres-
ence of GAPDH was confirmed with α-GAPDH (which 
detects GAPDH from M.tb as well as M. smegmatis) 
[9] and α-His antibodies to confirm the presence of 
rGAPDH-His (Fig. 1a; Additional file 3: Table 1). A sin-
gle band of 40  kD corresponding to the expected size 
of the native M. smegmatis GAPDH was detected in all 
fractions of the untransformed strain (Fig. 1a). In trans-
formed cells, besides native GAPDH, an additional 42 kD 
protein corresponding to the expected size of rGAPDH 
was observed. Though rGAPDH was present in all frac-
tions it was predominantly localized in the cell wall 
(Fig. 1a). Reprobing with α-His antibody confirmed that 
the 42 kD protein was rGAPDH (Fig. 1a).
Next, M.tb H37Ra was transformed with the same con-
struct, western blots probed with α-GAPDH and α-His 
antibodies (Fig.  1b) confirmed expression of the 42  kD 
rGAPDH in all fractions, in accordance with previous 
results where parent strains of both M.tb H37Ra and M.tb 
H37Rv demonstrate the presence of GAPDH in all sub-
cellular fractions [9, 11–13]. In controls (untransformed) 
the 40 kD native GAPDH was detected with α-GAPDH 
antibody. As compared to the expression observed in M. 
smegmatis, only a minor amount of native GAPDH was 
detected in the cytosol of the M.tb H37Ra transformant, 
indicating that rGAPDH is highly expressed and consti-
tutes the predominant species (Fig. 1a, b).
Protein purification by Ni–NTA chromatography
Purification of EC-H-GAPDH from the soluble fraction 
was done using published protocols [10] and confirmed 
by SDS-PAGE and western blotting (Additional file  1: 
Figure 1c). Unlike previous reports on purification from 
E. coli BL21DE3 [10], we found that supplementation 
with 1.0 mM NAD+ was not essential during purification 
from either mycobacterial host. However, affinity purified 
MS-GAPDH-H demonstrated the presence of two dis-
tinct proteins of ~42 kD (rGAPDH) and ~40 kD (native 
M. smegmatis GAPDH) (Fig.  1c). Detection with α-His 
antibody, confirmed that only the ~42  kD protein was 
rGAPDH however both proteins were detectable with 
α-GAPDH (Fig. 1d). The ~40 kD protein band was iden-
tified to be that of native M. smegmatis GAPDH (79  % 
coverage, MOWSE score 44) by peptide mass finger-
printing (Fig.  1e). The observation that native M. smeg-
matis GAPDH co-purifies with MS-GAPDH-H suggests 
the formation of heteromers. In contrast, purification 
from M.tb H37Ra resulted in a single prominent band of 
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~42  kD of rGAPDH (Fig.  1f ), as confirmed by western 
blotting with both antibodies (Fig. 1g).
Intact mass analysis of purified recombinant pro-
tein from M.tb H37Ra and E. coli revealed the presence 
of a single predominant species of 37.99 and 38.144 kD 
respectively (Additional file  2: Figure  2a, b, Additional 
file  3: Table  2). Purified recombinant proteins from all 
three sources were then subjected to 2D gel electropho-
resis (Additional file  2: Figure  2c–e). Trace amounts of 
associated native GAPDH was detected upon expression 
in M.tb H37Ra (pI 5.6) and M. smegmatis (pI 5.42) hosts 
reconfirming the formation of heteromers (Additional 
file 2: Figure 2c, d). The pI of recombinant MT-GAPDH-
H, MS-GAPDH-H and EC-H GAPDH were 6.43, 6.37 
and 6.57 respectively (Additional file  2: Figure  2c–e, 
Additional file  3: Table  3). As expected, GAPDH 
sequences from M.tb H37Rv and M.tb H37Ra strains 
were identical. M. smegmatis GAPDH demonstrates a 
Fig. 1 Localization and purification of recombinant M.tb GAPDH. a Localization of rGAPDH in cellular fractions of M. smegmatis detection was done 
using α-GAPDH and α-His antibodies. b Localization of rGAPDH in cellular fractions of M.tb H37Ra detection was done using α-GAPDH and α-His 
antibodies. c Affinity purification of MS-GAPDH-H, analysis by 10 % SDS-PAGE. d Western blot with α-GAPDH and α-His to confirm purification from 
M. smegmatis. e Peptide mass fingerprinting (PMF) of 40 kD M. smegmatis protein that co-elutes with rGAPDH. Identified sequences are indicated in 
bold face. f Affinity purification of MT-GAPDH-H. g Western blot with α-GAPDH and α-His to confirm purification from M. tb H37Ra
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high degree of sequence identity (88 % identity and 94 % 
similarity) which could account for heteromer formation 
with rGAPDH. E. coli GAPDH shares 52 % identity and 
69  % similarity with M.tb H37Rv GAPDH (Additional 
file 1: Figure 1d).
Since the experimental and theoretical intact mass val-
ues differed, the post translational modifications (PTMs) 
of rGAPDH purified from individual hosts were evalu-
ated by LC–MS/MS. PTM’s in M.tb influence various 
biological activities such as protease resistance, stability, 
compartmentalization, membrane anchoring, protein–
ligand interactions and protein degradation [14]. Analy-
sis revealed that MT-GAPDH-H had enhanced PTMs, 
including phosphorylation, deamidation, methylation 
and succinylation as compared to EC-H-GAPDH. The 
highest number of PTMs (69) were observed in MS-
GAPDH-H, in comparison native M. smegmatis GAPDH 
had far fewer modifications (36). Phosphorylation, deam-
idation, methylation, dimethylation, pro-pyro-glu and 
acetylation were all enhanced in MS-GAPDH-H as com-
pared to native M. smegmatis GAPDH (Additional file 3: 
Table 4). Detailed methodology for Peptide mass finger-
printing, 2D gel electrophoresis, sequence analysis and 
LC MS/MS are provided (Additional file 4). 
Expression and purification of MS‑H‑GAPDH 
and MT‑H‑GAPDH
Expression of N-terminal tagged His tagged protein was 
also carried out in M. smegmatis (Fig.  2a, b) and M.tb 
H37Ra (Fig.  3c, d). The fractionation results were com-
parable to expression of C-terminal tagged protein. Pro-
tein was purified from M. smegmatis (Fig. 2e, f ) and M.tb 
H37Ra (Fig. 2g, h). The enzyme activity of recombinant 
N-and C-His tagged GAPDH purified from M.tb H37Ra 
was comparable, indicating that position of the His tag 
did not affect enzyme activity (Fig. 2i).
Enzyme kinetics
A recent study on the purification and characteriza-
tion of rGAPDH from E. coli, indicated that the enzyme 
is unstable in the absence of NAD+ [10]. In contrast to 
those observations, our investigations revealed that 
NAD+ supplementation was not necessary for purifica-
tion of protein expressed in either mycobacterial host 
strain. The kinetic parameters for MT-GAPDH-H and 
MS-GAPDH-H were evaluated to ascertain whether they 
are at variance with reported values for E. coli expressed 
enzyme [10].
The Km and Vmax (G3P) of MT-GAPDH-H (Fig.  3a) 
and the corresponding values for MS-GAPDH-H 
were estimated (Fig.  3c). However, the reported values 
(Km 280 ±  30  µM and Vmax 1670 ±  90  min−1) [10] for 
M.tb rGAPDH purified from E. coli are very different. 
Similarly, the Km (NAD+) of recombinant enzyme for 
MT-GAPDH-H (Fig. 3b) and of MS-GAPDH-H (Fig. 3d) 
were different from the Km of 40 ± 4 µM reported previ-
ously for M.tb H37Rv rGAPDH purified from E. coli, per-
haps because the enzyme used for these experiments was 
saturated with NAD+ during the purification process. 
[10]. Data is summarized in Table 1.
Circular dichroism (CD spectroscopy)
Since Km and Vmax values for rGAPDH varied consider-
ably we considered whether these differences could be 
attributed to structural differences. The CD spectra of 
EC-H GAPDH and MT-GAPDH-H were determined and 
it was established that secondary structures are essen-
tially comparable with an α-helicity of 28 % (Fig. 3e).
pH stability
In contrast to previous findings that E. coli derived 
rGAPDH was unstable outside the pH range of 5.5–8.5 
[10], MT-GAPDH-H retained 70  % residual activity 
even in the pH range of 7.5–11.5, with an optimal stabil-
ity at pH 9.5, however, below pH 7.5, a significant loss of 
enzyme activity was observed (Fig. 3f ).
Thermal denaturation
In the presence of 1  mM NAD+, both MT-GAPDH-H 
and EC-H-GAPDH were stable in the temperature range 
of 15–65  °C. In the absence of 1 mM NAD+ a decrease 
in enzyme activity of MT-GAPDH-H was observed in the 
range of 37–50 °C, with a drastic loss of enzyme activity 
at 60  °C. Above 65  °C the enzyme lost activity irrespec-
tive of the presence or absence of NAD+ (Fig.  3g). EC-
H-GAPDH could not be assessed without NAD+ due to 
instability of the enzyme in these conditions.
Effect of H2O2 and metal ions
GAPDH from other species is known to be a redox sen-
sitive protein containing an active site cysteine residue 
which is susceptible to oxidation [15]. Disulfide bond for-
mation results in decreased enzymatic activity, which can 
be minimized by addition of the reductant 2-mercaptoe-
thanol (β-ME) [10]. In case of MT-GAPDH-H and M.tb 
H37Rv cytosol, only 20  % activity was retained in the 
presence of 250  µM H2O2. In contrast enzyme activity 
was unaffected by 250 µM H2O2 in the presence of 1 mM 
β-ME (Fig.  3h). All divalent metal ions tested (Cd2+, 
Cu2+, Co2+, Fe2+) inhibited enzyme activity to vary-
ing extents irrespective of the presence of 1  mM β-ME 
(Fig. 3i).
Modulation of multifunctional activity
Apart from enzymatic properties we evaluated whether 
moonlighting functions were also affected. Far western 
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blotting was utilized to confirm the interaction of trans-
ferrin with rGAPDH individually purified from each 
host. While MT-GAPDH-H, MT–H-GAPDH and MS-
GAPDH-H demonstrated a distinct interaction with 
human transferrin (Fig.  4a–c) EC-H-GAPDH failed to 
capture any detectable levels of transferrin (Fig.  4d). 
Since native conformations are likely to be essential for 
optimal ligand–receptor interaction at the cell surface, 
co-immunoprecipitation assays with all four recombinant 
proteins were carried out (Fig.  4e–g). Densitometry 
revealed that as compared to MT-GAPDH-H, a 70  % 
decrease of rGAPDH-transferrin interaction as evident 
using EC-H-GAPDH (p ≤ 0.001) (Fig. 4e, h). No change 
in GAPDH-transferrin interaction was observed with 
MS-GAPDH-H (Fig.  4f, h). Both N- and C-terminal 
8XHis tagged GAPDH from M.tb H37Ra showed com-
parable results suggesting that the position of the tag did 
not affect the transferrin binding property (Fig. 4g, h).
Fig. 2 Localization and purification of recombinant N-terminal His tagged M.tb GAPDH from M. smegmatis and M.tb H37Ra strains: Localization of 
rH-GAPDH in cellular fractions of M. smegmatis detection was done using a α-GAPDH and b α-His antibodies. Localization of rGAPDH in cellular 
fractions of M.tb H37Ra detection was done using c α-GAPDH and d α-His antibodies. e Affinity purification of MS-H-GAPDH, analysis by 10 % SDS-
PAGE. f Western blot with α-GAPDH and α-His to confirm purification from M. smegmatis. g Affinity purification of MT-H-GAPDH. h Western blot with 
α-GAPDH and α-His to confirm purification from M. tb H37Ra. i Comparative enzyme activity of N- (MT-H-GAPDH) and C-terminal (MT-GAPDH-H) His 
tagged recombinant GAPDH purified from M.tb H37Ra. Inset: Comparison of end point values, experiment was repeated three times (n = 3), data is 
represented as absorbance at 340 nm ±SD
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Expression of M.tb H37Rv PykA and Enolase in M.tb H37Ra
M.tb H37Rv PykA and Enolase recombinant proteins 
have been named EC-PykA-H, MS-PykA-H, MT-PykA-
H, EC-H-Enolase, MS-H-Enolase and MT-H-Enolase to 
indicate the host strain, tag and protein.
Expression and purification of M.tb PykA was also car-
ried out in all three hosts, in E. coli, maximum expression 
was evident in the inclusion body (IB) fraction (Fig. 5a). 
In M. smegmatis the recombinant protein was detected 
Fig. 3 Characterization of rGAPDH: determination of Km and Vmax for G3P and NAD
+ of a, b MT-GAPDH-H and c, d MS-GAPDH-H. The extent of 
enzymatic conversion was monitored by the formation of NADH at 340 nm at 25 °C. a, c The substrate NAD+ was added in excess (1 mM) while G3P 
was varied (0.02–2 mM). b, d Substrate G3P was in excess (2 mM), while NAD+ was varied from 0.01 to 2 mM. Data is fitted to Michaelis–Menten 
equation. Inset Data represented as a Lineweaver–Burk plot. e Comparative CD spectra of rGAPDH purified of MT-GAPDH-H and EC-H-GAPDH. f 
The activity was measured for 2 min, data is plotted as % residual activity versus pH. Average of three independent experiments is represented. g 
Temperature stability of rGAPDH-His. Data is plotted as % residual activity representing the average of three independent experiments. h Sensitivity 
of MT-GAPDH-H and M.tb H37Rv cytosol to H2O2 in the presence or absence of β-ME. i Sensitivity of MT-GAPDH-H to metal ions in the presence or 
absence of β-ME. Data is represented as % residual activity ±SD, n = 3
Table 1 Km and  Vmax values of  rGAPDH purified from  dif-
ferent host strains




E. coli BL21DE3 13 280 ± 30 1670 ± 90
40 ± 4
M. smegmatis 223.8 ± 4.66 0.128 ± 0.0023 109.4 ± 3.4
M.tb H37Ra 169.6 ± 10.53 0.199 ± 0.012 101.2 ± 8.9
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in all fractions but maximally in the cell wall fraction 
of (Fig.  5b). In M.tb H37Ra while maximum expression 
was observed in the cytosol, protein was also detected in 
membrane and cell wall fractions (Fig.  5c). The protein 
was purified from cytosolic fractions of all three strains 
(Fig. 5d–i). Upon expression in M. smegmatis, heteromer 
formation with native M. smegmatis PykA was evident on 
SDS-PAGE and western blotting (Fig. 5f, g). The identity 
of the 50  kD was confirmed to be native M. smegmatis 
PykA by peptide mass fingerprinting, the sequence cov-
erage was 58 % and MOWSE score was 191 (Additional 
file 2: Figure 2f ). In comparison to EC-PykA-H, recombi-
nant MT-PykA-H and MS-PykA-H demonstrated signifi-
cantly greater stability over time even in the absence of 
the co-factors Mg2+ and K+ [16] (Fig. 5j). Supplementa-
tion with Mg2+ [17] failed to restore the enzyme activity 
of EC-PykA-H, which was significantly lower than that 
of MT-PykA-H. MS-PykA-H also demonstrated loss of 
Fig. 4 Host strain affects the moonlighting function (transferrin binding) of rGAPDH: far western blotting demonstrates that binding of recom-
binant GAPDH to transferrin varies with the host strain. a MT-GAPDH-H, b MT-H-GAPDH, c MS-GAPDH-H and d EC-H-GAPDH. The interaction 
of GAPDH with transferrin was detected using polyclonal rabbit α GAPDH antibody. rGAPDH from each source represents the positive control 
while BSA has been utilized as a negative control. Co-immunoprecipitation analysis comparing capture of: e MT-GAPDH-H and EC-H-GAPDH, f 
MT-GAPDH-H and MS-GAPDH-H. g MT-GAPDH-H and MT-H-GAPDH Blots were probed with polyclonal rabbit α GAPDH antibody (to determine 
capture) and α transferrin antibody (to confirm that equal amounts of transferrin were used). h Densitometry analysis, co-immunoprecipitation of 
MT-GAPDH-H was taken as 100 %. Experiments were repeated multiple times, data is represented as a histogram depicting % binding ± SD, n = 3, 
***p ≤ 0.001
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Fig. 5 Localization, purification and activity of recombinant M.tb PykA in different host strains. a–c Localization of rPykA-H in cellular fractions of 
E. coli BL21DE3 GroEL/ES strain, M. smegmatis and M.tb H37Ra respectively, detection was done using α-His antibodies. d Affinity purification of 
EC-PykA-H, analysis by 10 % SDS-PAGE e Western blotting with α-His antibody. f Affinity purification of MS-PykA-H, analysis by 10 % SDS-PAGE. g 
Western blotting with α-PykA and α-His antibodies. h Affinity purification of MT-PykA-H, analysis by 10 % SDS-PAGE. i Western blotting with α-His 
antibodies. Residual enzyme activity (in %) of EC-PykA-H, MS-PykA-H and MT-PykA-H in the j absence of cofactors or in the presence of k Mg2+ or l 
K+. Significance was determined by student’s unpaired t-test where *p < 0.05; **p < 0.01 and ***p < 0.001
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activity over time as compared to MT-PykA-H (Fig. 5k). 
Addition of K+ marginally improved the stability of 
EC-PykA-H over time, however both activity and stabil-
ity were significantly lower than the corresponding values 
for MT-PykA-H or MS-PykA-H under the same condi-
tions (Fig. 5l).
In E. coli, EC-H-Eno was maximally localized to the 
cell wall (Fig. 6a), while in M. smegmatis the protein was 
detected in cytosol, cell membrane and cell wall (Fig. 6b). 
In M.tb H37Ra, maximum expression was detected in the 
cytosol and to a lesser extent in the cell membrane and 
cell wall fractions (Fig.  6c). The protein was purified by 
Ni-affinity chromatography from E. coli (Fig.  6d, e) and 
both mycobacterial strains as confirmed by SDS PAGE 
and western blotting with anti-His antibody (Fig.  6f–i). 
All three proteins (EC-H-Eno, MS-H-Eno and MT-H-
Eno) were functional, however Mg2+ was required to 
ensure optimal activity (Fig. 6j, k). It was observed EC-H-
Eno demonstrated significantly lower activity compared 
to proteins purified from mycobacterial strains. Supple-
mentation with Mg2+ could not fully restore the enzyme 
activity of EC-H-Eno as compared to MS-H-Eno or MT-
H-Eno (Fig. 6j, k).
Discussion
The current study establishes M.tb H37Ra as a suitable 
alternate host for expression of GAPDH and other pro-
teins from the pathogenic strain M.tb H37Rv. The avail-
ability of adequate quantities of any purified recombinant 
protein is essential for definitive in vitro and in vivo stud-
ies. E. coli has served as a well established expression host 
for many proteins due the availability of a large number 
of strains, plasmids and short generation time. However, 
successful expression of M.tb proteins has often been dif-
ficult in E. coli with major constraints being insolubility 
and poor yields [18]. To improve the yield of functional 
protein several strategies such as usage of codon opti-
mized strains, culture conditions and refolding protocols 
have been considered [1]. As an alternative the fast grow-
ing M. smegmatis strain has often been as used as a host 
for expression of M.tb proteins [4–6].
While trying to define the alternate roles of the con-
served tetrameric glycolytic enzyme GAPDH we encoun-
tered difficulties in obtaining sufficient quantities of 
functional protein. Initially we attempted purification 
using the expression strains E. coli BL21DE3-GroEL/
GroES [10] and M. smegmatis. In both cases, the yield 
of rGAPDH was ~1.0 mg/l of culture. As reported previ-
ously, supplementation of all buffers with 1  mM NAD+ 
was essential to obtain functionally active rGAPDH from 
E. coli [10]. rGAPDH expressed in M. smegmatis was 
more stable and did not have an absolute requirement 
for 1 mM NAD+ during purification steps. However, we 
observed that an additional ~40  kD molecule co-elutes 
along with rGAPDH on denaturing SDS-PAGE. Pep-
tide mass fingerprinting confirmed this to be native M. 
smegmatis GAPDH. The formation of GAPDH hetero-
tetramers has been reported previously in other species 
[19]. It therefore appears that M. smegmatis may not be 
an ideal expression system due to the formation of chi-
meric proteins. To obtain pure rGAPDH we successfully 
utilized the attenuated M.tb H37Ra strain as an expres-
sion system. Intact mass analysis of the recombinant 
protein (MT-GAPDH-H) was of 37.99 kD which closely 
corresponds to the theoretical value (37.78 kD). On SDS-
PAGE the protein is visible at 42kD, its anomalous mobil-
ity could be attributed to its hydrophobicity [20].
Expression in this strain did not require additional sup-
plementation of NAD+ during the purification steps. The 
yield increased to more than twofold (2.5  mg/l of cul-
ture), with the prominent species being that of rGAPDH. 
Since GAPDH has 100 % sequence conservation between 
M.tb H37Ra and M.tb H37Rv the presence of minute 
amounts of contaminating native protein would not sig-
nificantly affect the end product.
We then carried out biochemical characterization of 
rGAPDH and defined its functional differences in terms 
of both enzymatic activity as well as an alternate moon-
lighting function (transferrin binding) using protein puri-
fied from all sources. We found a wide variation between 
the Km and Vmax values determined for rGAPDH purified 
from M.tb H37Ra as compared with rGAPDH derived 
from M. smegmatis (this study) or as reported previously 
for protein expressed in E. coli [10]. We then analyzed 
other parameters such as pH stability, thermal denatura-
tion and effect of metal ions that could not be evaluated 
in earlier studies [10]. In contrast to previous findings 
[10], rGAPDH from M.tb H37Ra was functional even in 
the pH range of 7.5–11.5 (Fig. 3f ). It is well documented 
that macrophages, drugs and vitamin C generate super-
oxide, hydrogen peroxide (H2O2) and hydroxyl radicals 
as a bactericidal mechanism [21, 22]. Oxidation by H2O2 
inhibits the activity of several proteins including GAPDH 
and causes translocation of mammalian GAPDH to 
the nucleus, where it plays a role in DNA repair [23]. 
GAPDH is also reported to be inhibited by divalent 
metal ions [24], our current findings establish that M.tb 
GAPDH enzyme activity is inhibited by both H2O2 and 
divalent metal ions. Inhibition by Cu2+ and Cd2+ was 
limited in the presence of 1 mM β-ME indicating the role 
of the active site cysteine residues. CD analysis of E. coli 
and M.tb derived rGAPDH suggested that the second-
ary structures of the two proteins is essentially similar 
and may not contribute towards observed alterations in 
kinetic properties and protein stability.
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Fig. 6 Localization, purification and activity recombinant M.tb Enolase in different host strains. a–c Localization of rH-Enolase in cellular fractions of 
E. coli BL21DE3 GroEL/ES, M. smegmatis and M.tb H37Ra strains respectively, detection was done using α-His antibodies. d Affinity purification of EC-
H-Eno, analysis by 10 % SDS-PAGE e Western blotting with α-His antibody. f Affinity purification of MS-H-Eno), analysis by 10 % SDS-PAGE. g Western 
blotting with α-His antibodies. h Affinity purification of MT-H-Eno, analysis by 10 % SDS-PAGE. i Western blotting with α-His antibody. Residual 
enzyme activity (in %) of EC-H-Eno, MS-H-Eno and MT-H-Eno j in the absence of Mg2+, k in the presence of Mg2+. Significance was determined by 
student’s unpaired t test where *p < 0.05; **p < 0.01 and ***p < 0.001
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Finally, we analyzed whether the source of rGAPDH 
affects its role as a transferrin receptor, it was estab-
lished that rGAPDH derived from E. coli does not effec-
tively interact with human holo-transferrin. A 70  % 
loss in transferrin binding was observed as compared 
to rGAPDH purified from M.tb H37Ra. This is the first 
report to suggest that a receptor-ligand interaction is 
altered due to the source of the recombinant protein. 
The position of the His tag at the N or C-terminus did 
not affect the purification requirements, enzyme activity 
or alternate function of protein expressed in M.tb H37Ra. 
In the case of heteromeric protein purified from M. smeg-
matis no change in GAPDH-Tf interaction was observed 
which can be explained by the fact that M. smegmatis 
native GAPDH itself interacts with transferrin [9].
To establish that this host system is suitable for other 
M.tb proteins, we also assessed the expression of M.tb 
H37Rv pyruvate kinase (Rv1617) and Enolase (Rv0687). 
Both enzymes have not been fully characterized and are 
multimeric and multifunctional in M.tb and other species 
[7, 25]. As with GAPDH, maximal cytosolic localization 
was evident in M.tb H37Ra. A large amount of protein 
was present in the inclusion body fraction (PykA) or cell 
wall (Enolase) during E. coli expression. Dimerization 
with native protein from M. smegmatis was evident in 
the case of PykA. Expression of M.tb pyruvate kinase and 
Enolase in E. coli M15 strain is known to result in insol-
uble IB associated protein [26]. In the current study, an 
approximately four-fold increase in yield of Enolase was 
evident upon purification from M.tb H37Ra (12 mg/l) as 
compared to E. coli (2.75 mg/l) in the absence of Mg2+. 
Under these conditions the yield from M. smegmatis was 
4.5  mg/l. Upon supplementation with Mg2+ the yield 
changed to 16  mg/l (MT-H-Eno); 8.5  mg/l (MS-H-Eno) 
and to 4  mg/l for EC-H-Eno. The activity and stabil-
ity of both recombinant proteins obtained from E. coli 
was significantly lower as compared to proteins purified 
from M.tb H37Ra. In the case of PykA, supplementation 
with K+, marginally improved the activity and stability of 
EC-PykA-H. Enolase from E. coli host (EC-H-Eno) con-
sistently demonstrated lower activity (with or without 
Mg2+) as compared to recombinant MT-H-Eno. Pyru-
vate kinase obtained from M. smegmatis strain revealed 
decreased activity as compared to protein purified from 
M.tb H37Ra.
Proteomic analysis has previously revealed that PTMs 
can generate a diverse variety of protein species from a 
single translated molecule which provides cells the abil-
ity to rapidly switch functions upon specific demand. 
In prokaryotes, the role of these modifications is still in 
the process of being elucidated [14]. Apart from phos-
phorylation, several studies have identified that lysine 
acetylation and succinylation are vital for the regulation 
of protein function. Of the several proteins identified a 
majority belonged to the category of metabolic enzymes 
[27, 28]. Such modifications are predicted to regulate the 
activity of glyoxalate pathway enzymes Isocitrate lyase 
(Icl) and Malate synthase (GlcB) [27]. In M.tb, acetylation 
and succinylation negatively regulate the enzyme, protein 
tyrosine phosphatase B (PtpB) [29]. Other reports suggest 
that while modification sites may be partially conserved 
the number of modifications and site specificity may vary 
depending on the organism and strain [30, 31]. In the 
context of M.tb, previous studies have shown that the 
source of recombinant protein may affect the immuno-
genicity, protein–protein interaction and antibiotic sen-
sitivity due to changes in PTMs [32, 33]. GAPDH from 
several bacteria are known to possess post-translational 
modifications, M.tb GAPDH is reported to be phospho-
rylated, pupylated, succinylated and acetylated [29]. The 
current study demonstrated that rGAPDH from all three 
hosts are enzymatically active with significant variation 
in terms of activity. Our results reveal that the pattern of 
PTMs demonstrated by rGAPDH varies depending on 
the host expression strain (Additional file 3: Table 4), and 
could indicate a role for host specific PTMs in protein 
function. Detailed studies to elaborate the significance of 
individual PTMs would be required to fully understand 
their relevance in protein function.
The broader implications of our studies are that the 
expression host may drastically affect not only solubil-
ity, stability and localization but more importantly func-
tionality of recombinant M.tb proteins. Thus the source 
of a recombinant protein is an important parameter for 
the outcome of in  vitro, in  vivo studies such as enzyme 
assays, drug design, drug screening, vaccine develop-
ment and should closely represent the pathogen. This 
may also be true for studies involving proteins of other 
pathogenic microorganisms that are obtained from E. 
coli host expression systems. To effectively uncover func-
tional aspects of identified proteins, important param-
eters including sequence conservation, multimerization 
and PTMs must be carefully considered while attempt-
ing to utilize E. coli or M. smegmatis as expression hosts 
for M.tb proteins. In summary, our findings indicate that 
M.tb H37Ra has the advantage of being closely related to 
M.tb H37Rv, thereby precluding most challenges asso-
ciated with heterologous host expression. An added 
advantage is that M.tb H37Ra is an attenuated strain 
not requiring stringent containment facilities. The dis-
advantages of the system include the expense in terms 
of media, electroporation and long duration for M.tb 
H37Ra expression (10 days) as compared to E. coli (30 h) 
or M. smegmatis (48  h). A BSL2 compliant laboratory 
with appropriate biosafety cabinet and trained manpower 
would also be necessary to utilize this method. Overall, 
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the use of M.tb H37Ra coupled with the availability of 
newer vectors for expression [34] could increase the yield 




M.tb H37Ra and M. smegmatis mc2155 strains were 
obtained from MTCC, IMTECH, Chandigarh. Both 
strains were maintained in Middlebrook’s 7H9 medium 
or 7H10 supplemented with glycerol, OADC and Tween 
80 at 37  °C. E. coli BL21DE3 (Novagen) was used for 
expression by pET vector.
Plasmids and constructs
pET28c (Novagen) was utilized for expression in E. coli. 
The E. coli-Mycobacterium shuttle vector pSC300 was 
received as a gift from Prof. Y Av Gay (Department of 
Medicine, University of British Columbia). This vector 
contains the gene for enhanced GFP (Green Fluorescent 
Protein) downstream of a strong constitutive promoter 
superoxide dismutase (SOD) [35]. The GroEL/ES plasmid 
was received as a gift from Dr. T. Shrader [36] and Dr. JS 
Blanchard, Albert Einstein School of Medicine, USA [10].
Cloning of M.tb GAPDH in pET28c
The M.tb GAPDH (Rv1436) gene sequences were 
retrieved from TBDB (Tuberculosis Data Bank, http://
www.tbdb.org). PCR amplification was carried out 
using M.tb genomic DNA (BEI resources) to incorpo-
rate required restriction sites (Additional file 3: Table 1). 
Products were then cloned in the pET28c vector to 
obtain an inframe N-terminal His tag. The constructs 
were confirmed by sequencing and transformed into E. 
coli BL21DE3 cells, selection was done with kanamycin 
(30  µg/ml). This recombinant strain was also co-trans-
formed along with the GroEL/ES plasmid [10, 36], where 
selection was with tetracycline (6  µg/ml) in addition to 
kanamycin. Individual colonies were analyzed for pro-
tein expression and purification which was carried out as 
described previously [10]. Cytosol, cell wall and inclusion 
body fractions were prepared by standard methods [37] 
and the presence of recombinant protein in various cel-
lular fractions was determined by western blotting using 
monoclonal α-His antibody (1:3000) (Sigma).
Cloning of M.tb GAPDH in pSC300 vector
The M.tb GAPDH gene was cloned in the pSC300 vector 
for expression in Mycobacterial strains. Splicing by over-
lap extension PCR (SOE PCR) was used to incorporate a 
thrombin cleavage site, a glycine linker at the C-terminal 
end of GAPDH, 8XHis tag and Cla I site in two sequential 
PCR reactions. Primers SOE 1 and 3 were used for the 
first reaction, the product was reamplified using primers 
SOE 2 and SOE 3 in the second step.
A similar approach was taken to create the N-termi-
nal tagged GAPDH, SOE PCR was used to incorporate 
a enterokinase cleavage site and a glycine linker at the 
N-terminal end of GAPDH in the first PCR reaction. The 
primers SOE-N1 and SOE-N3 were used for this amplifi-
cation step. The SOE product I was then amplified with 
SOE-N2 and SOE-N3 primers to include the 8XHis tag 
and BamHI site preceding the glycine linker (Additional 
file 3: Table 1). The parent pSC300 plasmid was digested 
with BamHI and ClaI enzymes to remove the exist-
ing GFP gene and the GAPDH-Thrombin site-8XHis 
(C terminal tagged fragment) or 8XHis-Enterokinase 
site-GAPDH (N terminal tagged fragment) fragment 
were inserted in the vector after digestion with the same 
enzymes. Plasmids pGAPDH-His and pHis-GAPDH 
were as confirmed by sequencing.
Expression and localization of rGAPDH‑His/rHis‑GAPDH 
from M. smegmatis and M.tb H37Ra
Electroporation in M. smegmatis and M.tb H37Ra was 
done as described previously [9]. A single colony from 
each transformation was cultured in 7H9 media supple-
mented with OADC and 50 µg/ml hygromycin up to log 
phase. Sub cellular fractions were prepared and analysed 
for the presence of recombinant GAPDH by western 
blotting [9]. Briefly, 40  µg each of cytosol, cell mem-
brane and cell wall fractions from M. smegmatis and M.tb 
H37Ra transformed with either plasmid were denatured 
by heating for 10 min at 95 °C and loaded on a 10 % SDS-
PAGE. Control fractions of untransformed M. smegmatis 
and M.tb H37Ra were run alongside. Resolved proteins 
were either stained with coomassie blue or were trans-
ferred onto nitrocellulose membrane. Blots were probed 
with mouse monoclonal α-His (Sigma) for 1  h followed 
by incubation with goat α-mouse IgG-HRP (1:10,000 for 
1 h), washed and developed with TMB/H2O2. Blots were 
also stripped and re-probed with 1:1000 dilution of rab-
bit polyclonal α-GAPDH followed by detection with 
1:16,000 dilution of α-Rabbit-HRP (Sigma).
Purification of rGAPDH‑His and rHis‑GAPDH from M. 
smegmatis and M.tb H37Ra
Start up cultures of M. smegmatis or M.tb H37Ra trans-
formed with either plasmid were set up in 5  ml of 7H9 
broth and utilized to inoculate a fresh 500  ml batch of 
media at an initial OD600 of 0.05. Cultures were then incu-
bated at 37  °C with shaking at 200 rpm and maintained 
till log phase i.e. ~OD 0.8–1.0. Cells were harvested and 
washed once with PBS, pellets were then resuspended 
in cell lysis buffer (50  mM Tris pH 8.0, 150  mM NaCl) 
containing 1  mM PMSF and protease inhibitor cocktail 
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(Sigma). Samples were sonicated and the lysate was cen-
trifuged at 1000g for 10  min at 4  °C. The protein con-
centration of the lysate was adjusted to ~1.5 mg/ml and 
centrifuged (27,000g, 1 h at 4 °C) to pellet down the cell 
wall fraction. The supernatant (containing cytosol and 
cell membrane) was ultra centrifuged (1,00,000g for 2 h at 
4 °C) to pellet down the cell membrane. The supernatant 
(cytosol) was filtered using a 0.2 µ filter and loaded onto 
a Ni–NTA column pre-equilibrated with 50  mM Tris 
pH 8.0 containing 150 mM NaCl. The column was thor-
oughly washed with buffer containing 30 mM imidazole 
followed by elution with buffer containing 250 mM imi-
dazole. Proteins were immediately dialyzed into 50 mM 
Tris, 150 mM NaCl and 1 mM β-ME pH 8.0, aliquoted, 
flash frozen and stored at −80 °C for further use.
GAPDH enzyme assay
GAPDH enzyme assays were performed essentially 
as described previously [9]. Briefly, 0.25  µg of purified 
enzyme was added into 200  µl of assay buffer (50  mM 
HEPES, 10  mM sodium arsenate and 5  mM EDTA, pH 
8.5), 1  mM NAD+ and 2  mM glyceraldehyde-3-phos-
phate (G3P, Sigma) at 25 °C. Enzyme activity was meas-
ured as the increase in absorbance at 340  nm due to 
formation of NADH. To compare the activity of N- and 
C-terminally His tagged proteins, absorbance was moni-
tored over 5 min. For negative controls, assays were car-
ried out with buffer lacking the specific substrate G3P, 
these values were subtracted from the final absorbance.
Determination of Km and Vmax
For kinetic studies, Michaelis constant (Km) for G3P was 
determined by varying the concentration of G3P (from 
0.02 to 2  mM) while maintaining a constant amount of 
NAD+ (1  mM). The Km for NAD+ was determined by 
varying concentrations of NAD+ (from 0.01 to 2  mM) 
and holding G3P concentration constant at 2  mM. 
Sodium arsenate was used at a saturating concentration 
of 10 mM for all assays. All enzyme reactions were car-
ried out at 25 °C in assay buffer. The velocities were cal-
culated from the initial linear portion of the reaction and 
considering the molar extinction coefficient of NADH 
(6220  M  cm−1) along with the total enzyme concentra-
tion. Values of the Michaelis constants (Km) and maximal 
velocity (Vmax) were calculated using Lineweaver–Burk 
plot. One unit of enzyme activity was defined as the 
amount of enzyme that catalyzes the formation of 1 μmol 
NADH/min under the conditions used.
Circular dichroism (CD) spectroscopy
CD spectra of MT-GAPDH-H and EC-H-GAPDH were 
recorded using a Jasco J-815 CD spectropolarimeter. 
The enzyme was dialyzed in 20 mM phosphate buffer 
pH 7.4 containing 1 mM NAD+ and was adjusted to a 
concentration of 0.25  mg/ml. The CD spectrum was 
recorded from 200 to 250  nm at 25  °C using a cell 
of 0.1  cm path length. Buffer containing NAD+ was 
taken as blank and its values were subtracted from the 
corresponding spectrum. Experiments were repeated 
thrice and the overlay spectrum of molar ellipticity v/s 
wavelength (nm) of representative experiment is pre-
sented [38].
pH stability
Purified MT-GAPDH-H was incubated in different buff-
ers ranging from pH 5.5–11.5 for 30  min at 25  °C. The 
buffers used were 50  mM MES buffer for pH 5.5 and 
6.5, 50  mM HEPES buffer for pH 6.5, 7, 7.5, 8 and 8.5; 
50 mM Glycine-NaOH for pH 8.5, 9 and 9.5; CAPS buffer 
(50  mM) was used for pH 9.5, 10, 10.5 and 11.5. After 
incubation the enzyme activity was determined at 25 °C 
using assay buffer. The activity was measured for 2 min, 
data is plotted as percentage residual activity versus pH.
Thermal denaturation
The purified MT-GAPDH and EC-H-GAPDH along with 
1 mM NAD+ were incubated at a range of temperatures 
between 15 and 80 °C for 10 min and then maintained at 
25 °C for 2 min. The enzyme activities were measured as 
before. Data is plotted as percent residual activity versus 
temperature. For MT-GAPDH-H a parallel set of experi-
ments was also run in the absence of 1 mM NAD+. Aver-
age of three independent experiments is represented.
Effect of H2O2 and metal ions
All assays were carried out essentially as described for 
characterization of GAPDH from other species. Purified 
MT-GAPDH-H (1  µM) was supplemented with either 
250 µM H2O2 or with individual metal ions (Cu+2, Cd+2, 
Co+2 or Fe+2) at 4  °C for 10  min in 50  mM Tris–HCl 
buffer pH 7.4 with or without 1  mM 2β-ME. GAPDH 
enzyme activity was measured for 2 min in assay buffer 
lacking EDTA. Experiments were repeated thrice inde-
pendently, data is plotted as % residual activity ±SD 
(n = 3).
Far western blotting
Far western blotting was carried out as described earlier 
[9] briefly 3  µg of transferrin was run on a 10  % SDS-
PAGE and transferred to nitrocellulose. The membrane 
was then probed with 10  µg/ml of either recombinant 
GAPDH from E. coli or M. smegmatis or M.tb H37Ra. 
Binding of GAPDH to transferrin was detected using 
α-GAPDH, all experiments were repeated thrice.
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Co‑immunoprecipitation of transferrin and rGAPDH
Co-immunoprecipitation was performed essentially as 
described previously [9]. Briefly, 2.5 µM of transferrin-
biotin was first mixed with 10  µl of streptavidin para-
magnetic particles (SAPMP’s, Pierce) for 1 h at 4 °C on 
a rotospin. The particles were washed with PBS and 
incubated for 2  h at 4  °C with 2.5  µM of recombinant 
GAPDH purified from each of the host systems. After 
washing with PBS, particles were resuspended in 30 µl 
of Laemmli sample buffer, boiled and loaded on a 10 % 
SDS-PAGE gel. Captured GAPDH was detected by 
western blotting using α-GAPDH antibody as described 
previously. Captured transferrin was also detected using 
1:1000 rabbit α-Tf antibody (Abcam), to serve as the 
loading control. Blots were analyzed by densitometry 
using Quantity One software (BioRad) to quantitate 
the amount of GAPDH captured. Experiments were 
repeated three times independently, data is plotted as 
% binding ±SD. Statistical analysis was done using stu-
dent’s t test.
Cloning of M.tb H37Rv PykA and Enolase in E. coli 
expression vectors
The M.tb PykA (Rv1617) and Enolase (Rv1023) genes 
were PCR amplified from M.tb H37Rv genomic DNA 
(BEI resources) with forward and reverse primers con-
taining NdeI and HindIII sites respectively (Additional 
file  3: Table  1). The products were then individually 
cloned in the pET 30a (PykA, C-terminal His tagged) or 
pET28c (Enolase, N-terminal His tagged) vectors. Plas-
mids pET30-PykA-His and pET28-His-Eno were con-
firmed by sequencing.
Cloning of M.tb H37Rv PykA and Enolase in mycobacterial 
expression vector
The M.tb pykA gene was cloned in the pSC300 vector 
using Splicing by overlap extension PCR (SOE PCR) to 
incorporate an enterokinase cleavage site and a glycine 
linker at the C-terminal end of PykA in the first PCR 
reaction. The primers PykA-SOE-1 and PykA-SOE-2 
were used for this amplification step (Additional file  3: 
Table  1). The SOE product I was then amplified with 
PykA-SOE-1 and PykA-SOE-3 primers to include the 
8XHis tag and ClaI site after the glycine linker. The par-
ent pSC300 plasmid was digested with BamHI and ClaI 
enzymes to remove the existing GFP gene and the PykA-
Enterokinase site-8XHis fragment was inserted in the 
vector after digestion with the same enzymes.
For Enolase, the parent pSC300 plasmid was digested 
with BamHI and ClaI enzymes to remove the existing 
GFP gene and a cassette (containing 8X His tag followed 
by NdeI and HindIII sites) was inserted in the vector. This 
cloned vector pHis300 was further digested with NdeI 
and HindIII and the same PCR amplified M.tb H37Rv 
enolase product was digested and inserted at this site 
to obtain in-frame N-terminal His tag gene. Both plas-
mid pPykA-His and pHis-Enolase were confirmed by 
sequencing. Plasmids were transformed into M. smeg-
matis or M.tb H37Ra strains as described previously for 
pGAPDH-His.
Expression and localization of rPykA‑His and rHis‑Enolase 
in E. coli
The plasmids were transformed into E. coli BL21DE3 
GroEL/ES strain, selection was done with kanamy-
cin (30  µg/ml) and tetracycline (6  µg/ml). Single colo-
nies were isolated and analyzed for protein expression 
and purification. Cultures were grown in LB media at 
30  °C and induced with 0.1  mM IPTG at an OD600 of 
0.5–0.6, cultures were then maintained at 18 °C for 15 h. 
Cells were harvested by centrifugation and pellets were 
stored at −20  °C. Cell pellets were resuspended in lysis 
buffer PykA (50  mM Tris pH 8.0, 150 NaCl) and Eno-
lase (50  mM Tris pH 8.0) containing 1  mM PMSF and 
protease inhibitor cocktail. Cytosol, cell wall and inclu-
sion body fractions were prepared by standard meth-
ods as described earlier for rGAPDH and the presence 
of recombinant protein in various cellular fractions was 
determined by western blotting using monoclonal α-His 
antibody (1:3000).
Expression and localization of rPykA‑His, rHis‑Enolase 
from M. smegmatis and M.tb H37Ra
Electroporation and preparation of sub cellular frac-
tions from M. smegmatis and M.tb H37Ra was done 
as described for GAPDH. Samples (40  µg each) were 
analyzed on a 10  % SDS-PAGE, control fractions of 
untransformed M. smegmatis and M.tb H37Ra were run 
alongside. Resolved proteins were either stained with 
coomassie blue or were transferred onto nitrocellulose 
membrane. Blots were probed with mouse monoclonal 
α-His (Sigma) for 1  h followed by incubation with goat 
α-mouse IgG-HRP (1:10,000 for 1 h), washed and devel-
oped with TMB/H2O2.
Proteins have been referred to as EC-PykA-His, 
MS-PykA-H, MT-PykA-H and EC-H-Enolase, MS-H-
Enolase, MT-H-Enolase to reflect the expression host, 
position of tag and protein.
Purification of recombinant PykA from E. coli, M. smegmatis 
or M.tb H37Ra strains
The induced cell pellet was resuspended in lysis buffer 
(50  mM Tris pH 8.0, 150  mM NaCl) containing PMSF 
and protease inhibitor cocktail. Cells were processed as 
described for recombinant GAPDH purification from E. 
coli.
Page 15 of 17Boradia et al. Microb Cell Fact  (2016) 15:140 
Start up cultures and cell pellets from M. smegmatis 
or M.tb H37Ra transformed with pPykA-His were set up 
as described for GAPDH. Pellets were resuspended in 
lysis buffer (50 mM Tris, pH8.0, 150 mM NaCl) contain-
ing 1 mM PMSF and protease inhibitor cocktail (Sigma). 
Lysates from all three hosts were processed as before to 
obtain the cytosol, the pre-filtered fraction loaded onto 
a Ni–NTA column pre-equilbrated with lysis buffer. The 
column was thoroughly washed with buffer containing 
35  mM imidazole followed by elution with buffer con-
taining 250  mM imidazole. Proteins were immediately 
dialyzed into 50 mM HEPES pH 7.5 or 50 mM HEPES pH 
7.5 supplemented with either 10 mM MgCl2 or 100 mM 
KCl. Protein was aliquoted, flash frozen and stored at 
−80  °C for further use. Purification was confirmed by 
coomassie staining of 10  % SDS-PAGE and by western 
blotting using monoclonal α-His antibody. PykA was also 
assessed using affinity purified Rabbit polyclonal anti-
body (0.5 µg/ml). The antibody was custom synthesized 
by Bioneeds, Bangalore, India using IB fraction obtained 
from E. coli. The ~50  kD protein that co-elutes with 
MS-PykA-H was subjected to PMF as done for GAPDH.
Enzymatic assay for Pyruvate kinase
Pyruvate kinase enzyme assay was performed to compare 
the activity of recombinant protein purified from three 
different sources. To evaluate stability, samples were 
stored at 4  °C for a period of 0–72  h. Pyruvate kinase 
assay buffer [39] (100 µl) containing 50 mM HEPES pH 
7.5, 10 mM MgCl2, 50 mM KCl, 2 mM adenosine diphos-
phate, 10  mM sodium phosphoenol pyruvate, 0.3  mM 
NADH, 1.5 U lactate dehydrogenase was preincubated at 
25 °C for 3 min. Pyruvate kinase (100 ng) was added and 
the decrease in absorbance at 340 nm was monitored for 
1 min. For negative controls, assays were carried out with 
buffer lacking the specific substrate sodium phosphoenol 
pyruvate; these values were subtracted from the final 
absorbance. Experiments repeated thrice in duplicates. 
For each set of experiments, data has been plotted as % 
residual activity ±SD v/s time (h) by considering activ-
ity of MT-PykA-H at 0 h as 100 %. Data was analyzed by 
Student’s unpaired t test.
Purification of recombinant Enolase from E. coli, M. 
smegmatis and M.tb H37Ra strains
The induced E. coli cell pellet was resuspended in lysis 
buffer i.e. 50  mM Tris pH 8.0 containing PMSF and 
protease inhibitor cocktail. Cells were processed as 
described for recombinant GAPDH purification from E. 
coli. Start up cultures and cell pellets from M. smegma-
tis or M.tb H37Ra transformed with pHis-Eno were set 
up as described for GAPDH. Pellets were resuspended 
in lysis buffer (50 mM Tris pH 8.0 containing PMSF and 
protease inhibitor cocktail). Lysates from all three hosts 
were processed as described previously. The column was 
thoroughly washed with buffer containing 20 mM imida-
zole followed by elution with buffer containing 250 mM 
imidazole. Proteins were immediately dialyzed into 
50 mM HEPES, pH 7.0, aliquoted, flash frozen and stored 
at −80 °C for further use. To ascertain the effect of Mg2+, 
purification was also performed by supplementing all 
buffers with 5 mM MgSO4. Purification was confirmed by 
coomassie staining of 10 % SDS-PAGE and western blot-
ting using monoclonal α-His antibody.
Enzyme assay for Enolase
Enolase enzyme assay was performed as described pre-
viously [40] to compare the activity of recombinant 
protein purified from three different hosts. The effect 
of Mg2+ on enzyme activity and enzyme stability over a 
period of 0–10  h was evaluated time points of 0, 6 and 
10  h are depicted. Enolase assay buffer [50  mM HEPES 
pH 7.0, 7.7 mM KCl, 10 mM MgSO4 and 9 mM D (+)-2 
phosphoglyceric acid sodium salt (2-PG)] was prein-
cubated at 37  °C for 3  min. Purified enolase was added 
at a concentration of 1 µg per 100 µl of buffer at 37  °C, 
the increase in absorbance at 240 nm was monitored for 
5 min. For negative controls, assays were carried out with 
buffer lacking the specific substrate 2-PG, these values 
were subtracted from the final absorbance. Experiments 
repeated thrice in duplicates, for each set of experiments, 
data has been plotted as % residual activity ±SD v/s time 
(h) by considering activity of MT-H-ENO at 0 h as 100 %. 
Data was analyzed by Student’s unpaired t test.
Additional files
Additional file 1: Figure 1Expression of rGAPDH in E. coli. a. Expression 
of EC-H-GAPDH in cellular fractions of E. coli-GroEL/ES strain assessed by 
10 % SDS PAGE and b. confirmation by western blotting using Mouse 
α His antibody. c. Affinity purified EC-H-GAPDH and western blot with 
α-GAPDH and α-His to confirm purification from E. coli host cytosol.  
d. ClustalW analysis of GAPDH from M.tb H37Rv, M.tb H37Ra, M. smegmatis 
and E. coli.
Additional file 1: Figure 2Intact mass analysis and isoelectric point of 
recombinant M.tb GAPDH. MALDI-TOF confirms the presence of a single 
protein corresponding to a. MT-GAPDH-H and b. EC-H-GAPDH. Two 
dimensional gel analysis of rGAPDH purified from different source c. MT-
rGAPDH d. MS-rGAPDH e. EC-rGAPDH where the gel was either stained 
with coomassie or western blot using rabbit α-GAPDH or mouse α-His.  
f. Peptide mass fingerprinting (PMF) of ~ 50 kD M. smegmatis protein that 
co-elutes with rPykA. Identified sequences are indicated in bold face.
Additional file 3. Details of primers used, experimental and theoretical 
molecular weights, pI values and details of post-translational modifica-
tions in GAPDH.
Additional file 4. Methodology for Peptide Mass Fingerprinting, 
Sequence analysis, 2D gel electrophoresis and LC MS/MS of GAPDH.
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M.tb: Mycobacterium tuberculosis; GAPDH: glyceraldehyde-3-phosphate dehy-
drogenase; rGAPDH: recombinant GAPDH; PykA: pyruvate kinase; Eno: Enolase; 
G3P: glyceraldehyde-3-phosphate; NAD+: nicotinamide adenine dinucleotide; 
Tf: transferrin; PTMs: post-translational modifications; PMF: peptide mass 
fingerprinting.
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